Skip to main content
. 2022 Feb 6;12(2):226. doi: 10.3390/jpm12020226

Figure 2.

Figure 2

Subgroup analysis of overall survival, cancer-specific survival, and disease-free survival according to baseline characteristics. HR—hazard ratio; CI—confidence interval; CIS—carcinoma in situ; LVI—lymphovascular invasion.